Trucheck is a new blood-based paradigm in multicancer detection. The Intelli test can detect over 70 different types of solid tumours and only requires 25ml blood sample.  The test will provide either a negative or positive result. A negative result suggests that no circulating tumour cells were detected in the given blood sample with 88.2% sensitivity rate. A positive result occurs when CTCs are detected in the given blood sample which is suggestive of malignancy with 99.9% sensitivity. This can be further analysed to determine the tissue or organ of origin. Following your blood draw results, our clinical director will provide you with a consultation and next steps.

CTCs are not detected in cancer-free individuals or those with benign (non-cancerous) conditions. CTCs permit detection of cancers with high sensitivity and enable differentiation between cancer patients and healthy individuals with high specificity.

If Circulating Tumour Cells (CTCs) are not detected, this indicates a lower risk of the presence of cancer. Please be mindful that this does not completely rule out the presence of cancer as some cancers may not shed detectable tumour cells in the blood. We still advise you to seek advice from a medical professional or contact us if new symptoms arise and continue partaking in the national screening programmes.

We will send an experienced health practitioner to your home for a home visit appointment at no extra cost if you would prefer.

Download the Trucheck Intelli brochure here.

Hereditary cancer is defined as cancer that has been caused by an inherited genetic variant. The Hereditary Cancer Panel involves testing for inherited genetic variants that are associated with an increased cancer susceptibility risk.

The Hereditary Cancer Panel includes 31 different genes and has been expertly curated using current literature and national testing guidelines to maximise clinical actionability, whilst minimising uncertainty. This multi-cancer panel targets genes associated with breast, ovarian, colorectal, prostate, melanoma, and pancreatic cancer.

The full gene list for this panel is shown below:

APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53, VHL.

The FIT test is used to identify possible signs of bowel cancer. It determines this by detecting the quantity of human haemogolobin (blood) in stool samples with 88% sensitivity and 91% specificity for colorectal cancer. An increased quantity of haemoglobin in stool samples is present in individuals with diseases that involve haemorrhagic lesions in the gut such as intestinal tumours or their precursors. In such cases, individuals with a positive FIT result can be referred for further investigation usually through colonoscopy or CT colonoscopy. 

During an MRI scan, the patient lies down on a table that slides through a large tunnel containing powerful magnets. It is this strong magnetic field that allows doctors to see inside your body in a way previously only possible through surgery. It is suitable for every part of your body, including bones, soft tissues and the brain, and is one of the most advanced imaging techniques used to date.

The MRI scan of your head will show us any damage to your:

• Brain
• Blood vessels

Based on the results, you may be found to have:

• Brain tumours
• Aneurysms
• Infections
• Inflammation
• Haemorrhage

We’ll scan the entire length of your spine. This includes:

• Cervical spine
• Thoracic spine
• Lumbar spine
• Coccyx
• Vertebrae
• Intervertebral discs
• Spinal cord
• Other tissues surrounding the spine

The images will be used to diagnose any of the following conditions:

• Fractures
• Vertebrae collapse
• Nerve compression
• Tumours
• Herniated discs
• Improper spine curvature
• Abdomen

We'll cover an overview of the abdominal organs. This includes:

• Kidneys
• Liver
• Spleen
• Biliary tract
• Pancreas (to some degree)
• Gallbladder
• Overview of the aorta, renal arteries and lymph nodes

The scan will show any damage that may indicate any of these pathologies:

• Tumours in your organs
• Cirrhosis
• Gallstones
• Pelvis (Musculoskeletal)

A pelvis MRI scan will show the inner structures of your:

• Pelvic girdle
• Muscles and ligaments

You may be diagnosed with any of the conditions below:

• Fractures
• Polyps and tumours
• Infections
• Osteoarthritis

This makes the scan a very useful screening tool and does not use harmful radiation. The images are reviewed by an experienced clinical radiologist and a full written report is provided to you after a telephone consultation, to explain the results. The reading and reporting of the scan is vital because it is important to know which anomalies need to be examined further and which need not raise any concerns. This is where a human eye will be superior to an AI machine reading.

The anxiety, pain, risks, and costs associated with invasive biopsies for cancer diagnosis are substantial. Yet till date, a reliable, safe, and non-invasive test to establish a diagnosis in suspected cases of cancer has not been available. Trublood® is a revolutionary non-invasive, cost-effective, safe and accurate blood test that can substitute invasive biopsies in most suspected cases of solid tumours and brain tumours. Starting with a simple 25ml blood draw, the process involves extremely sensitive, sophisticated and careful isolation and analysis of live circulating tumour cells.

Download Trublood Solid Organ brochure here.